Aspo: Aspo: EBIT to rise above EUR 40m next year - Evli (Evli Research)

Marimekko: Marimekko: Flat sales expected for Q1 - Evli (Evli Research)

Nepa: Nepa: Ask questions to Redeye's analyst (Redeye)

LifeClean International: LifeClean International: Ask questions to Redeye's analyst (Redeye)

I-tech: I-Tech: Ask questions to Redeye's analyst (Redeye)

Railcare Group: Railcare Group: Ask questions to Redeye's analyst (Redeye)

Moberg Pharma: Moberg Pharma: Ask questions to Redeye's analyst (Redeye)

Scandinavian ChemoTech: Scandinavian ChemoTech: Ask questions to Redeye's analyst (Redeye)

Grangex: Equity Research | GRANGEX: Striking renegotiation of Sydvaranger acquisition setting GRANGEX up for an eventful 2024 (Emergers)

Sitowise Group: Sitowise Q1 morning result: Operational development weakened as we had expected in the first months of the year (Inderes)

IRLAB Therapeutics: IRLAB Therapeutics: MSRD agreement early validation for IRL757 - Edison (Edison Investment Research)

Gaming Innovation Group: Gaming Innovation Group - Building for the long term (ABG Sundal Collier)

Nodebis Applications: Första intrycket Nodebis, kv1 2024: Omsättning något under förväntan (Carlsquare)

Stenocare: Equity Research Report on STENOCARE - New Products Paves the way for Further Patient Growth (Analyst Group)

G5 Entertainment: G5 Entertainment Q1: EBIT above expectations - SEB (SEB Research)

Agillic: Agillic (One-pager): Balancing the business to market conditions (HC Andersen Capital via Inderes)

Gaming Innovation Group: Gaming Innovation Group - Inleder året med nya rekord (Penser Access)

Carlsquare/Vontobel weekly trading note: Strong Q1 2024 season and outlook in the US (Carlsquare)

Sprint Bioscience: Sprint Bioscience Q1: Improved sales and activity (Redeye)

Incap: Flash Comment: Q1 above consensus, FY guidance unchanged (Nordea)

InfraCom Q1 2024: Mixed-bag (Redeye)

Anora Group: Margin on an upward trend (Inderes)

Relais Group: Flash Comment: Strong start for the year supported by cold weather conditions (Nordea)

IRLAB Therapeutics: IRLAB Therapeutics - Q1 report: building up IRL757 (ABG Sundal Collier)

Infracom Group: Infracom Groups rörelseresultat över förväntningarna (Pinpoint Estimates)

Metacon: Metacon enters strategic collaboration with Siemens to support its factory project (Inderes)

Fantasma Games: Fantasma Games Q1 2024: Better than expected with strong incremental margins (Redeye)

Taaleri: Investment income boosted a strong Q1 (Inderes)

Investors House: Flash Comment: Strong reported Q1 results on asset revaluations (Nordea)

Arise: Arise - Stabilt kvartal trots avsaknad av projektförsäljningar och låga intäkter från Lebo (Penser Access)

MGI - Media and Games Invest: Navigating effectively in a dynamic market (Inderes)

QleanAir: QleanAirs rapport under förväntningarna (Pinpoint Estimates)

Componenta: After bottoming out (Inderes)

Premium Snacks Nordic: Premium Snacks rapport över förväntningarna (Pinpoint Estimates)

Ascelia Pharma: Ascelia Pharma: Medvind i seglen (Penser Access)

Maven Wireless Sweden: Maven Wireless: Rekordhög bruttomarginal, men något lägre orderingång än vi hoppats på (Penser Access)

Motion Display Scandinavia: Equity Research | MOTION DISPLAY: Another strong quarter confirming that MODI has turned the corner (Emergers)

IRLAB Therapeutics: IRLAB: Development collaboration with MSRD/Otsuka regarding IRL757 (Redeye)

Carlsquare weekly letter: Sell in May and stay away? (Carlsquare)

G5 Entertainment: G5 Entertainment Q1 2024: Soft topline but solid profitability (Redeye)

Embellence Group: Embellence Group - Legacy brands keep growing abroad (ABG Sundal Collier)